Iovance Biotherapeutics Announces April Scientific and Investor Presentations

On March 29, 2019 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, reported that the company will present at the following conferences in April (Press release, Iovance Biotherapeutics, MAR 29, 2019, View Source;p=RssLanding&cat=news&id=2392771 [SID1234534740]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting in Atlanta, March 29-April 3
Title: Persistence of cryopreserved tumor-infiltrating lymphocyte product lifileucel (LN-144) in C-144-01 study of advanced metastatic melanoma
Authors: Viktoria Gontcharova et al.
Session Title: Late-Breaking Research: Immunology 1
Session Type: Late-Breaking Poster Session
Section: 41
Abstract Number: LB-069

Location: Georgia World Congress Center
Date/Time: Monday, April 1, from 8:00 a.m. – 12:00 p.m. EDT
Jefferies 6th Annual IO Cell Therapy Summit in Boston, April 5
Location: Boston Harbor Hotel
Date/Time: Friday, April 5, at 10:35 a.m. EDT

HC Wainwright Global Life Science Conference in London, April 7-9
Location: JW Marriott Grosvenor House London
Date/Time: Tuesday, April 9, at 9:50 a.m. BST
A live and archived webcast of the presentation will be available by visiting the Investors section of the Iovance Biotherapeutics website at View Source

2019 Cell & Gene Meeting on the Mediterranean in Barcelona, April 23-25
Location: Hotel Arts Barcelona
Date/Time: Wednesday, April 24, at 12:00 p.m. CEST

15th European Association of Dermato-Oncology (EADO) Congress in Paris, April 24-27
Title: Safety and efficacy of cryopreserved autologous tumor infiltrating lymphocytes (LN-144, lifileucel) in previously treated metastatic melanoma patients (Encore presentation)
Location: Maison de la Chimie Conference Center
Date/Time: Thursday, April 25 at 2:07 p.m. CEST